Dr Dhabhar is a celebrated medical oncologist at Fortis Mulund with a distinguished career spanning more than 30 years in managing the most complex cancer conditions. Armed with super specialization in medical oncology and hemato oncology from Tata Memorial Hospital, Dr Dhabhar is highly respected among his peers for his precise diagnosis and staging of cancers, including adopting a logical approach in charting out the best and most effective treatment options for patients in all stages of malignancies, and across age groups.
At Fortis Mulund - India’s leading super specialty healthcare provider - Dr Dhabhar’s superior expertise involves the special care of cancer patients with low immunity given their delicate condition. Skilled in chemotherapy, administration of chemotherapeutic drugs for blood-related diseases and solid tumors, and the management and control of any toxicities or harmful effects of the drugs, Dr Dhabhar’s experience includes allied procedures such as bone marrow aspiration, biopsy and intrathecal or spinal injections. Not surprising that Dr Dhabhar is acclaimed for his high success rate in treating more than 20,000 cancer patients from all over the world at Fortis Mumbai.
Honored with a Certification from the European Society of Medical Oncology, Switzerland, of which he is also a Member, and, a Fellowship from Fred Hutchinson Cancer Research Center, Washington, and the University of Texas MD Anderson Cancer Center, USA, Dr Dhabhar is in the league of the topmost medical oncologists in the country.
Dr Dhabhar believes in consistently honing his skills on the state of the art, high precision medical technology for cancer diagnosis and treatment in which Fortis Mumbai is a leader. His focus is on managing chemotherapy-induced anemia in cancer patients, the efficacy of targeted therapies in certain tumors, bone marrow biopsy in the staging of lymphatic cancer, pain management, and counseling of cancer patients and their caregiving family.
Dr Dhabhar has keen interest in cancer research and has co-published around 34 research papers on various topics of cancer including infections associated with white blood cells, the pattern of malignant cancers, breast cancer, the incidence of lung cancer, and so on.